Category: Treatments

Posted on | Posted on John Murphy | Leave a Comment on A Unique Case of Unprovoked Pulmonary Venous Thrombosis in a Postpartum Female Following COVID-19 Infection

A Unique Case of Unprovoked Pulmonary Venous Thrombosis in a Postpartum Female Following COVID-19 Infection

Jordan Lipschutz • Sophia H. Ji • Mohammad Q. Jafri • Ambica Nair • Brian Kerr, 2024, DOI: 10.7759/cureus.64893 Abstract SARS-CoV-2 can induce a hypercoagulable state, occasionally resulting in pulmonary venous thrombosis (PVT) due to inflammation and endothelial injury.…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Federal Judge Forces FDA to Release Over a Million Pages of Pfizer’s COVID-19 Trial Documents They Wanted to Keep Hidden for 75 Years

Federal Judge Forces FDA to Release Over a Million Pages of Pfizer’s COVID-19 Trial Documents They Wanted to Keep Hidden for 75 Years

by Jim Hᴏft  The United States District Court for the Northern District of Texas ruled against the Food and Drug Administration (FDA) in a high-profile case brought by the Public Health…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Efficacy and safety of hyperbaric oxygen therapy for long COVID: a protocol for systematic review and meta-analysis

Efficacy and safety of hyperbaric oxygen therapy for long COVID: a protocol for systematic review and meta-analysis

Yuxin Li, Jingnan Lin, Jiazhu Gao et. al., http://orcid.org/0009-0000-2874-1861 Abstract Introduction There is still a lack of therapeutic options for long COVID. Several studies have shown the benefit of hyperbaric oxygen therapy (HBOT) on…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on House Select Committee on Coronavirus Releases Report on Social Distancing, COVID-19 Vaccine Mandates

House Select Committee on Coronavirus Releases Report on Social Distancing, COVID-19 Vaccine Mandates

Elizabeth Weibel The House Select Subcommittee on the Coronavirus Pandemic released a final report regarding its two-year investigation into social distancing, masking, and the COVID-19 vaccine mandates. In the 520-page…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Part of the NIH RECOVER Initiative, trials will test four treatments. The National Institutes of Health (NIH) will launch clinical trials to investigate potential treatments for long-term symptoms after COVID-19…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Mesenteric Panniculitis and COVID-19: A Rare Association

Mesenteric Panniculitis and COVID-19: A Rare Association

Authors: Israa A Alyousef,1Zainab A Alsaileek,1Manar A Alabdulsalam,1et. al. Cureus. 2022 Jan; 14(1): e21314. . doi: 10.7759/cureus.21314 PMCID: PMC8849467PMID: 35186573 Abstract Coronavirus disease 2019 (COVID-19) typically involves the respiratory system, but gastrointestinal involvement is common.…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Role of 2-Deoxy-D-Glucose in Enhancing the Efficacy of Standard of Care for Moderate to Severe COVID-19: A Comparative Analysis of Clinical Outcomes

Role of 2-Deoxy-D-Glucose in Enhancing the Efficacy of Standard of Care for Moderate to Severe COVID-19: A Comparative Analysis of Clinical Outcomes

Triven Sagar Sandepogu • Chennakesavulu Dara • Saranya Mallamgunta •, et. al. DOI: 10.7759/cureus.73993  Abstract Objective This study aimed to evaluate the role of 2-Deoxy-D-Glucose (2-DG) in moderate to severe Coronavirus Disease 2019 (COVID-19) cases. Methodology…[...]

Read More